Find uplifting stories about heroes, innovations, and solutions
17496 results for "cancer treatment breakthrough"
Blood cancer patients in Kansas can now access a one-time therapy that could replace lifelong chemotherapy cycles. The breakthrough CAR T-cell treatment genetically modifies patients' own immune cells to fight cancer.
A 58-year-old ovarian cancer patient in Manchester became the first person in the world to receive a pioneering therapy that could transform how we fight multiple types of cancer. The "off-the-shelf" treatment uses donated immune cells engineered to hunt down tumors.
A short burst of immunotherapy before surgery has kept every patient in a UK colorectal cancer trial cancer-free for nearly three years. The breakthrough challenges decades of standard treatment and offers hope for thousands.
Scientists in Japan discovered that an immune protein older than blood itself could help cancer treatments work better when it's produced directly inside tumors. The breakthrough has already extended survival in mice with treatment-resistant cancer.
A breakthrough treatment for pancreatic cancer shows promise in doubling how long patients survive with one of the deadliest forms of cancer. This medical advance offers new hope for thousands of families facing this devastating diagnosis.
Scientists at Oregon Health & Science University discovered that stress nerves help pancreatic tumors grow, opening doors to potential new treatments. The breakthrough could transform how we fight one of the deadliest cancers.
UK scientists created a simple blood test that tells doctors whether breast cancer treatment will work before therapy even begins. The breakthrough could spare patients from months of ineffective drugs and help them find treatments that actually work.
Bladder cancer patients now have access to breakthrough treatments that are improving survival rates and reducing recovery times. From robot-assisted surgery to personalized medicine, new advances are transforming what was once a limited treatment landscape into a field full of hope.
Patients with one of the deadliest forms of colorectal cancer are living more than twice as long thanks to a breakthrough treatment that just earned FDA Fast Track status. The therapy is showing remarkable results in cancers that resisted everything else doctors could throw at them.
Patients with muscle-invasive bladder cancer now have the first major treatment breakthrough in over 20 years. A new drug combination keeps 80% of patients disease-free two years after treatment, compared to 66% with standard chemotherapy.
A breakthrough trial shows that just nine weeks of immunotherapy before surgery has kept every colorectal cancer patient in the study cancer-free for nearly three years. The approach challenges decades of standard treatment and could change care for thousands of patients annually.
Doctors are catching ovarian cancer earlier and keeping it away longer with personalized treatments and genetic testing. These advances are giving patients real hope where there was once only uncertainty.
Multiple research teams discovered that aggressive lung cancer cells form actual connections with brain neurons, and drugs that block these connections slow tumor growth in mice. The breakthrough could lead to new treatment options for one of the deadliest cancers.
Women with aggressive double-positive breast cancer now have a powerful new treatment option after the FDA approved a therapy that extends the time without disease progression by more than 15 months. The breakthrough offers fresh hope for patients facing one of breast cancer's toughest challenges.
A Minnesota company just won FDA approval for a breakthrough prostate cancer treatment that uses steam instead of surgery. The 30-minute outpatient procedure could help 84% of newly diagnosed patients avoid invasive treatments.
A simple biomarker test is helping doctors identify which ovarian cancer patients can benefit from precision treatments that work like guided missiles against tumors. The breakthrough offers new hope especially for women whose cancer stopped responding to traditional chemotherapy.
Women with an aggressive form of breast cancer now have two powerful new treatment options that work better than chemotherapy alone. The drugs represent the first major breakthrough in over 20 years for treating metastatic triple-negative breast cancer.
Mayo Clinic researchers discovered that brigatinib, a lung cancer drug, may help ovarian cancer patients overcome treatment resistance when combined with existing therapies. The breakthrough could transform care for women facing one of the deadliest cancers.
A groundbreaking combination therapy is giving women with HER2-positive metastatic breast cancer significantly more time, setting a new standard for first-line treatment. The DESTINY-Breast09 trial shows the treatment works across different patient groups, offering hope to thousands.
Ochsner MD Anderson Cancer Center in New Orleans is bringing biology-guided radiotherapy to the South, becoming only the eighth facility worldwide to offer this precision cancer treatment. The technology uses cancer cells' own signals to guide radiation in real-time, potentially reducing side effects while treating tumors that are in motion.
Showing 20 of 17496